Ligand Pharmaceuticals Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Revenue	2,216	2,161	2,106	2,449	2,234	1,526	Upgrade
Revenue Growth (YoY)	5.84%	2.61%	-14.03%	9.65%	46.40%	8.46%	Upgrade
Cost of Revenue	978.5	962.75	1,005	1,207	1,060	722.17	Upgrade
Gross Profit	1,238	1,198	1,101	1,242	1,173	803.54	Upgrade
Selling, General & Admin	466.98	451.53	416.85	450.83	389.95	289.6	Upgrade
Other Operating Expenses	318.11	325.31	291.26	322.1	277.47	211.51	Upgrade
Operating Expenses	948.22	937.75	865.38	930.04	790.01	617.43	Upgrade
Operating Income	289.68	260.04	235.69	312.46	383.41	186.1	Upgrade
Interest Expense	-58.55	-63.4	-67.55	-54.05	-36.08	-33.53	Upgrade
Interest & Investment Income	3.88	3.67	1.39	-	-	-	Upgrade
Earnings From Equity Investments	0.05	0	0.02	0.07	0.01	0.03	Upgrade
Currency Exchange Gain (Loss)	-4.32	-0.15	-7.46	-13.9	-5.94	-9.66	Upgrade
Other Non Operating Income (Expenses)	-6.33	-6.93	-5.15	-11.32	0.58	-3.07	Upgrade
EBT Excluding Unusual Items	224.41	193.25	156.93	233.26	341.98	139.87	Upgrade
Impairment of Goodwill	-	-	-	-	-0.09	-	Upgrade
Gain (Loss) on Sale of Investments	-0.95	0.16	0.85	-	-	-	Upgrade
Gain (Loss) on Sale of Assets	-0.23	-0.1	0.91	0.14	0.35	-0.39	Upgrade
Asset Writedown	0.39	-0.22	-0.54	-8.28	-2	-1.66	Upgrade
Other Unusual Items	-	-	-	-	-2.74	1.2	Upgrade
Pretax Income	223.62	193.09	158.14	225.11	337.49	139.02	Upgrade
Income Tax Expense	58.61	51.03	41.29	60.71	81.52	39.12	Upgrade
Earnings From Continuing Operations	165.01	142.06	116.85	164.4	255.97	99.9	Upgrade
Net Income to Company	165.01	142.06	116.85	164.4	255.97	99.9	Upgrade
Minority Interest in Earnings	-3.33	-3.99	-3.02	-4.47	-3.61	-3.52	Upgrade
Net Income	161.68	138.07	113.83	159.93	252.36	96.39	Upgrade
Net Income to Common	161.68	138.07	113.83	159.93	252.36	96.39	Upgrade
Net Income Growth	32.88%	21.30%	-28.83%	-36.63%	161.82%	1058.23%	Upgrade
Shares Outstanding (Basic)	190	190	190	189	191	194	Upgrade
Shares Outstanding (Diluted)	190	190	190	189	191	194	Upgrade
Shares Change (YoY)	0.00%	0.10%	0.56%	-1.03%	-1.74%	-0.18%	Upgrade
EPS (Basic)	0.85	0.73	0.60	0.85	1.32	0.50	Upgrade
EPS (Diluted)	0.85	0.73	0.60	0.85	1.32	0.50	Upgrade
EPS Growth	32.88%	21.17%	-29.22%	-35.97%	166.47%	1060.36%	Upgrade
Free Cash Flow	206.92	271.23	390.78	70.64	299.72	270.23	Upgrade
Free Cash Flow Per Share	1.09	1.43	2.06	0.38	1.57	1.39	Upgrade
Dividend Per Share	0.600	0.600	0.550	0.700	0.850	0.610	Upgrade
Dividend Growth	9.09%	9.09%	-21.43%	-17.65%	39.34%	-	Upgrade
Gross Margin	55.85%	55.44%	52.29%	50.73%	52.53%	52.67%	Upgrade
Operating Margin	13.07%	12.04%	11.19%	12.76%	17.16%	12.20%	Upgrade
Profit Margin	7.29%	6.39%	5.41%	6.53%	11.30%	6.32%	Upgrade
Free Cash Flow Margin	9.34%	12.55%	18.56%	2.88%	13.42%	17.71%	Upgrade
EBITDA	361.12	352.94	331.74	415.61	463.7	263.4	Upgrade
EBITDA Margin	16.29%	16.34%	15.75%	16.97%	20.76%	17.26%	Upgrade
D&A For EBITDA	71.44	92.9	96.05	103.16	80.29	77.3	Upgrade
EBIT	289.68	260.04	235.69	312.46	383.41	186.1	Upgrade
EBIT Margin	13.07%	12.04%	11.19%	12.76%	17.16%	12.20%	Upgrade
Effective Tax Rate	26.21%	26.43%	26.11%	26.97%	24.15%	28.14%	Upgrade
Revenue as Reported	2,216	2,161	2,106	2,449	2,234	1,526	Upgrade
Advertising Expenses	-	33.29	31.15	36.3	26.21	17.16	Upgrade

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.